EG24978A
(en )
2011-04-03
Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment.
AP2006003525A0
(en )
2006-02-28
Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia.
DK1318992T3
(en )
2005-11-21
Imidazole derivatives as Raf kinase inhibitors
GB0121490D0
(en )
2001-10-24
Ciompounds
DE502004002801D1
(en )
2007-03-15
DRILLING TREATMENT AGENT, CONTAINING ETHERCARBOXYLIC ACIDS
NO20053042L
(en )
2005-06-21
Use of spongosine (2-methoxyadenosine) for the treatment of pain, especially hyperalgesia.
NO20055741L
(en )
2006-01-06
New chemical compounds
TNSN08400A1
(en )
2010-04-14
Organic compounds and their uses
TW200716088A
(en )
2007-05-01
Formulations and methods for treating amyloidosis
DE602006003094D1
(en )
2008-11-20
4-PHENYL-5-OXO-1,4,5,6,7,8-HEXAHYDROCHINOLINE DERIVATIVES FOR THE TREATMENT OF BARRENESS
IL151146A0
(en )
2003-04-10
Process and device for the treatment of water, particularly for ships
ZA200509966B
(en )
2006-11-29
The treatment of water containing dissolved gases
EP1254260A4
(en )
2003-07-23
Methods for diagnosing and treating heart disease
YU89103A
(en )
2006-08-17
Novel treatment for obsessive-compulsive disorder (ocd) and ocd-related disorders using gvg
GB0121494D0
(en )
2001-10-24
Compounds
MXPA06007007A
(en )
2007-06-08
Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours.
PT1092040E
(en )
2005-06-30
METHODS OF INHIBIT HELICOBACTER PYLORI
UA67178A
(en )
2004-06-15
Antiseptic for preventing and treating salmonellosis of poultry
UA85187C2
(en )
2009-01-12
2-aminobenzoyl derivatives
HK1087027A1
(en )
2006-10-06
Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain
ATE423780T1
(en )
2009-03-15
MACROCYCLES FOR THE TREATMENT OF CANCER DISEASES
ATE390144T1
(en )
2008-04-15
TREATMENT OF FIBROSIS
NO20045437L
(en )
2004-12-13
Medications for the treatment of acute dysfunction in portavenous and hepatic circulation
RS52038B
(en )
2012-04-30
Use of 7-butoxyminomethylcamptothecin for treating uterine neoplasms
DE602004004354D1
(en )
2007-03-08
Formaldehyde-releasing composition for the treatment of aqueous systems